Ultan McDermott - Concepedia

Author

Ultan McDermott

Also Known As

Andrea L. Richardson, Andrew Biankin, Andrew Futreal, Campbell, PJ, Daniel J. Hodson, Erik Mayer, Faridah Mbabaali, Hayley C Whitaker, Hayley C. Whitaker, Jessica Zucman-Rossi

512

Publications

59.5K

Citations

H-Index

Concepts

All Affiliations

Wellcome Sanger Institute Massachusetts General Hospital Harvard University University of Cambridge European Bioinformatics Institute

About

Ultan McDermott is an author at Wellcome Sanger Institute specializing in medicine, cancer research, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	30	41	19.6K
2	Engineering	10	11	7.4K
3	Health Sciences	1	1	44
4	Natural Sciences	1	1	103
5	Public Health	1	1	265

Ultan McDermott

100

Publications

34.1K

Citations

H-Index

Page 1

	Year	Citations
Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells Wanjuan Yang, Jorge Soares, Patricia Greninger, Nucleic Acids Research Therapeutic Biomarker DiscoveryDrug TargetEngineeringPathologyTumor Biology	2012	4.2K
Pan-cancer analysis of whole genomes Lauri A. Aaltonen, Federico Abascal, Adam Abeshouse, Nature	2020	3.1K
A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations Sreenath V. Sharma, Diana Lee, Bihua Li, Cell ChromatinChromatin RemodelingMedicineCancer Cell BiologyCancer Cell Subpopulations	2010	2.7K
Systematic identification of genomic markers of drug sensitivity in cancer cells Mathew J. Garnett, Elena J. Edelman, Sonja J. Heidorn, Nature Systematic IdentificationGenomic MarkersEngineeringTumor HeterogeneityMedicine	2012	2.5K
COSMIC: exploring the world's knowledge of somatic mutations in human cancer Simon Forbes, David Beare, Prasad Gunasekaran, Nucleic Acids Research	2014	2.4K
Prospective Derivation of a Living Organoid Biobank of Colorectal Cancer Patients Marc van de Wetering, Hayley E. Francies, Joshua M. Francis, Cell OncologyBiobankMedicineColorectal CancerPathology	2015	2.4K
A Landscape of Pharmacogenomic Interactions in Cancer Francesco Iorio, Theo Knijnenburg, Daniël J. Vis, Cell Tumor BiologyOncologyTumor HeterogeneityMedicineDrug Response	2016	2.2K
Clinical Features and Outcome of Patients With Non–Small-Cell Lung Cancer Who Harbor <i>EML4-ALK</i> Alice T. Shaw, Beow Y. Yeap, Mari Mino–Kenudson, Journal of Clinical Oncology	2009	1.9K
A CRISPR Dropout Screen Identifies Genetic Vulnerabilities and Therapeutic Targets in Acute Myeloid Leukemia Konstantinos Tzelepis, Hiroko Koike-Yusa, Étienne De Braekeleer, Cell Reports Gene Deletion DataGeneticsAcute Myeloid LeukemiaTherapeutic TargetsGenetic Engineering	2016	784
Targeting MYCN in Neuroblastoma by BET Bromodomain Inhibition Alexandre Puissant, Stacey M. Frumm, Gabriela Alexe, Cancer Discovery Neuro-oncologyBromodomain InhibitionNovel TherapyOncogenic AgentMycn Transcription	2013	624

Page 1